Showing results (741-750 of 928) with videos related to

Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|February 7, 2020
Adolescent obesity and midlife cancer risk: a population-based cohort study of 2·3 million adolescents in IsraelAriel Furer, Arnon Afek, Adir Sommer, et al.
The Lancet. Diabetes & Endocrinology|November 20, 2020
Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trialDarren K McGuire, Bernard Zinman, Silvio E Inzucchi, et al.
The Lancet. Diabetes & Endocrinology|November 2, 2020
Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trialsKarine Clément, Erica van den Akker, Jesús Argente, et al.
The Lancet. Diabetes & Endocrinology|September 19, 2020
Intake and metabolism of omega-3 and omega-6 polyunsaturated fatty acids: nutritional implications for cardiometabolic diseasesMatthias B Schulze, Anne Marie Minihane, Rasha Noureldin M Saleh, et al.
The Lancet. Diabetes & Endocrinology|September 18, 2020
Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trialDenice S Feig, Lois E Donovan, Bernard Zinman, et al.
The Lancet. Diabetes & Endocrinology|September 18, 2020
Diabetes in ageing: pathways for developing the evidence base for clinical guidanceMedha N Munshi, Graydon S Meneilly, Leocadio Rodríguez-Mañas, et al.
The Lancet. Diabetes & Endocrinology|March 6, 2020
Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depressionThomas T van Sloten, Sanaz Sedaghat, Mercedes R Carnethon, et al.
The Lancet. Diabetes & Endocrinology|March 6, 2020
Glycaemic status during pregnancy and longitudinal measures of fetal growth in a multi-racial US population: a prospective cohort studyMengying Li, Stefanie N Hinkle, Katherine L Grantz, et al.
The Lancet. Diabetes & Endocrinology|January 26, 2019
Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trialInge B Halberg, Karsten Lyby, Karsten Wassermann, et al.
The Lancet. Diabetes & Endocrinology|December 19, 2013
Dynamics of childhood growth and obesity: development and validation of a quantitative mathematical modelKevin D Hall, Nancy F Butte, Boyd A Swinburn, et al.
Pageof 93